Veracyte’s Strong Q4 2024 Performance and Strategic Moves Justify Buy Rating
PremiumRatingsVeracyte’s Strong Q4 2024 Performance and Strategic Moves Justify Buy Rating
1M ago
Veracyte Inc. Reports Strong 2024 Financial Performance
Premium
Company Announcements
Veracyte Inc. Reports Strong 2024 Financial Performance
1M ago
Veracyte sees FY25 testing revenue $470M-$480M
Premium
The Fly
Veracyte sees FY25 testing revenue $470M-$480M
1M ago
Veracyte downgraded to Neutral from Buy at Goldman Sachs
PremiumThe FlyVeracyte downgraded to Neutral from Buy at Goldman Sachs
4M ago
Veracyte price target raised to $28 from $26 at Morgan Stanley
Premium
The Fly
Veracyte price target raised to $28 from $26 at Morgan Stanley
5M ago
Morgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
Premium
The Fly
Morgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
5M ago
Veracyte Inc. Reports Strong Q3 2024 Growth
PremiumCompany AnnouncementsVeracyte Inc. Reports Strong Q3 2024 Growth
5M ago
Veracyte reports Q3 adjusted EPS 33c, consensus 3c
Premium
The Fly
Veracyte reports Q3 adjusted EPS 33c, consensus 3c
5M ago
Veracyte raises FY24 revenue view to $442M-$445M from $432M-$438M
Premium
The Fly
Veracyte raises FY24 revenue view to $442M-$445M from $432M-$438M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100